It is an oxidative stress regulator, especially in bacteria and yeast and lipid metabolism in plants
LincoffAMBrown-FrandsenKColhounHMDeanfieldJEmersonSSEsbjergSet alSemaglutide and cardiovascular outcomes in obesity without diabetes
Sojkova J, Driscoll I, Iacono D, Zhou Y, Codispoti KE, Kraut MA, et al
Glutation a zwalczanie infekcji W wielu chorobach przewlekych saba odporno i zwikszona czsto infekcji s zwizane z niskim poziomem glutationu
The free form of aspartate is also limited in this dietary model because it activates N-methyl-D-aspartate receptors
10.1038/s41598-021-97967-0 Summary Keywords heart failure, GLP-1, glucagon-like peptide-1, clinical trials, cardiovascular disease, cardiovascular outcome studies, diabetes, obesity Citation Kreiner FF, Hovingh GKK and von Scholten BJ (2022) The potential of glucagon-like peptide-1 receptor agonists in heart failure